116 related articles for article (PubMed ID: 28272408)
1. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Xu J; Lange EM; Lu L; Zheng SL; Wang Z; Thibodeau SN; Cannon-Albright LA; Teerlink CC; Camp NJ; Johnson AM; Zuhlke KA; Stanford JL; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Maier C; Luedeke M; Vogel W; Schleutker J; Wahlfors T; Tammela T; Schaid D; McDonnell SK; DeRycke MS; Cancel-Tassin G; Cussenot O; Wiklund F; Grönberg H; Eeles R; Easton D; Kote-Jarai Z; Whittemore AS; Hsieh CL; Giles GG; Hopper JL; Severi G; Catalona WJ; Mandal D; Ledet E; Foulkes WD; Hamel N; Mahle L; Moller P; Powell I; Bailey-Wilson JE; Carpten JD; Seminara D; Cooney KA; Isaacs WB;
Hum Genet; 2013 Jan; 132(1):5-14. PubMed ID: 23064873
[TBL] [Abstract][Full Text] [Related]
2. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
[TBL] [Abstract][Full Text] [Related]
3. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.
Schroeck FR; Zuhlke KA; Siddiqui J; Siddiqui R; Cooney KA; Wei JT
J Urol; 2013 Mar; 189(3):849-53. PubMed ID: 23036981
[TBL] [Abstract][Full Text] [Related]
4. Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer.
Saunders EJ; Dadaev T; Leongamornlert DA; Jugurnauth-Little S; Tymrakiewicz M; Wiklund F; Al Olama AA; Benlloch S; Neal DE; Hamdy FC; Donovan JL; Giles GG; Severi G; Gronberg H; Aly M; Haiman CA; Schumacher F; Henderson BE; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock S; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Nordestgaard BG; Canzian F; Campa D; Riboli E; Key TJ; Travis RC; Ingles SA; John EM; Hayes RB; Pharoah P; Khaw KT; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Clements JA; Teixeira MR; Xu J; Mikropoulos C; Goh C; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; ; ; ; ; Easton DF; Muir K; Eeles RA; Kote-Jarai Z
PLoS Genet; 2014 Feb; 10(2):e1004129. PubMed ID: 24550738
[TBL] [Abstract][Full Text] [Related]
5. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A
Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843
[TBL] [Abstract][Full Text] [Related]
6. Differential Protein Expression Patterns of HOXA13 and HOXB13 Are Associated with Bladder Cancer Progression.
Chin FW; Hussin H; Chau DM; Ong TA; Yunus R; Abdul Razack AH; Yusoff K; Chan SC; Veerakumarasivam A
Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627895
[TBL] [Abstract][Full Text] [Related]
7. In silico modeling of the interaction between TEX19 and LIRE1, and analysis of TEX19 gene missense SNPs.
Alzahrani FA; Hawsawi YM; Altayeb HN; Alsiwiehri NO; Alzahrani OR; Alatwi HE; Al-Amer OM; Alomar S; Mansour L
Mol Genet Genomic Med; 2021 Jul; 9(7):e1707. PubMed ID: 34036740
[TBL] [Abstract][Full Text] [Related]
8. Identification of High-Risk Single Nucleotide Polymorphisms in the Human CYB5R3 Gene Responsible for Recessive Congenital Methemoglobinemia: A Computational Approach.
Bouatrous E; Nouira S; Menif S; Ouragini H
Mol Syndromol; 2023 Oct; 14(5):375-393. PubMed ID: 37901856
[TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches.
Sekhoacha M; Riet K; Motloung P; Gumenku L; Adegoke A; Mashele S
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080493
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic nsSNPs that increase the risks of cancers among the Orang Asli and Malays.
Khoruddin NA; Noorizhab MN; Teh LK; Mohd Yusof FZ; Salleh MZ
Sci Rep; 2021 Aug; 11(1):16158. PubMed ID: 34373545
[TBL] [Abstract][Full Text] [Related]
11. In silico analysis of a novel causative mutation in Cadherin23 gene identified in an Omani family with hearing loss.
Al-Kindi MN; Al-Khabouri MJ; Al-Lamki KA; Palombo F; Pippucci T; Romeo G; Al-Wardy NM
J Genet Eng Biotechnol; 2020 Mar; 18(1):8. PubMed ID: 32115674
[TBL] [Abstract][Full Text] [Related]
12. Molecular modelling and docking of Mus musculus HMGB1 inflammatory protein with CGA.
Tripathi A; Shrinet K; Singh VK; Kumar A
Bioinformation; 2019; 15(7):467-473. PubMed ID: 31485132
[TBL] [Abstract][Full Text] [Related]
13. The Role of HOX Transcription Factors in Cancer Predisposition and Progression.
Li B; Huang Q; Wei GH
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31013831
[TBL] [Abstract][Full Text] [Related]
14. The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.
Deng Y; He R; Zhang R; Gan B; Zhang Y; Chen G; Hu X
Oncol Lett; 2018 Jun; 15(6):8556-8572. PubMed ID: 29805592
[TBL] [Abstract][Full Text] [Related]
15. Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.
FitzGerald LM; Raspin K; Marthick JR; Field MA; Malley RC; Thomson RJ; Blackburn NB; Banks A; Charlesworth JC; Donovan S; Dickinson JL
Sci Rep; 2017 Dec; 7(1):17778. PubMed ID: 29259341
[TBL] [Abstract][Full Text] [Related]
16. Computational Modeling of complete HOXB13 protein for predicting the functional effect of SNPs and the associated role in hereditary prostate cancer.
Chandrasekaran G; Hwang EC; Kang TW; Kwon DD; Park K; Lee JJ; Lakshmanan VK
Sci Rep; 2017 Mar; 7():43830. PubMed ID: 28272408
[TBL] [Abstract][Full Text] [Related]
17. In silico analysis of the deleterious nsSNPs (missense) in the homeobox domain of human HOXB13 gene responsible for hereditary prostate cancer.
Chandrasekaran G; Hwang EC; Kang TW; Kwon DD; Park K; Lee JJ; Lakshmanan VK
Chem Biol Drug Des; 2017 Aug; 90(2):188-199. PubMed ID: 28072499
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
